BiotechTube
Home/Nova Eye Medical/Tom Spurling
TS

Tom Spurling

Chief Executive Officer

Nova Eye Medical

Therapeutic Areas

OphthalmologyGlaucoma

Nova Eye Medical Pipeline

DrugIndicationPhase
iTrack™ AdvanceOpen‑angle glaucomaFDA 510(k) cleared
iTrack™Open‑angle glaucoma (viscodilation)CE Marked
Molteno3®Complex glaucomaCommercial

Leadership Team at Nova Eye Medical

KH
Kate Hunt
Chief Commercial Officer
JB
Joe Bankovich
President, Global Sales
View full Nova Eye Medical profile